Boehringer Ingelheim and co-founder of the War On Cancer app, Sebastian Hermelin, invites you to listen in to the recently released podcast ‘Taking cancer on’, the podcast.
In an effort to simplify the science behind Boehringer Ingelheim’s ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.
Episode 1: Taking On The Beating Heart of Cancer
Expert Guest: Dr Darryl McConnell, Senior Vice President and Research Site Head for Boehringer Ingelheim, Austria
A breakthrough in KRAS research could mean improved treatment options for 1 in 7 cancer patients across the globe. With stats like that in mind, it’s easy to see why Dr Darryl McConnell is fascinated (some might even say obsessed) with KRAS-driven cancers, despite them being considered ‘undruggable’ for many decades.
In this episode we explore the very beginnings of cancer research. The discovery of drug candidates for new therapeutic concepts is the first key stepping-stone towards getting treatments to the patients who need them most.
Listen to the first episode of Taking Cancer On, the podcast here.
Or listen to the War On Cancer podcast season 1 here.